StreetInsider.com News Articles

Form 10-Q Syra Health Corp For: Jun 30

Tue, 11 Aug 2026 17:26:00 -0400

si-local-file:///var/storage/secattach/20260811/26907184.html

Form 10-Q Syra Health Corp For: Jun 30

Tue, 11 Aug 2026 17:26:00 -0400

si-local-file:///var/storage/secattach/20260811/26907184.html

Form 8-K Syra Health Corp For: Aug 11

Tue, 11 Aug 2026 08:37:00 -0400

si-local-file:///var/storage/secattach/20260811/26902181.html

Form 8-K Syra Health Corp For: Aug 11

Tue, 11 Aug 2026 08:37:00 -0400

si-local-file:///var/storage/secattach/20260811/26902181.html

Syra Health Achieves 23% Revenue Growth, Improves Gross Margin to 44.5% in Second Consecutive Profitable Quarter

Tue, 11 Aug 2026 07:55:00 -0400

Syra Health sustained profitability in Q2 2026, following the Company's first profitable quarter in Q1 2026, delivering net income of $250,242 compared with a net loss of $(63,596) in the prior-year period.
Q2 2026 revenue grew 23% year-over-year to $2.4 million.
Earnings per share (EPS) improved to $0.02 in Q2 2026 from a loss of $(0.01) in Q2 2025.
Gross margin increased to 44.5% in Q2 2026, up from 38.7% in Q2 2025.

CARMEL, Ind., Aug. 11, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), an integrated

Syra Health Achieves 23% Revenue Growth, Improves Gross Margin to 44.5% in Second Consecutive Profitable Quarter

Tue, 11 Aug 2026 07:55:00 -0400

Syra Health sustained profitability in Q2 2026, following the Company's first profitable quarter in Q1 2026, delivering net income of $250,242 compared with a net loss of $(63,596) in the prior-year period.
Q2 2026 revenue grew 23% year-over-year to $2.4 million.
Earnings per share (EPS) improved to $0.02 in Q2 2026 from a loss of $(0.01) in Q2 2025.
Gross margin increased to 44.5% in Q2 2026, up from 38.7% in Q2 2025.

CARMEL, Ind., Aug. 11, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), an integrated

Syra Health Achieves 23% Revenue Growth, Improves Gross Margin to 44.5% in Second Consecutive Profitable Quarter

Tue, 11 Aug 2026 07:55:00 -0400

Syra Health sustained profitability in Q2 2026, following the Company's first profitable quarter in Q1 2026, delivering net income of $250,242 compared with a net loss of $(63,596) in the prior-year period.
Q2 2026 revenue grew 23% year-over-year to $2.4 million.
Earnings per share (EPS) improved to $0.02 in Q2 2026 from a loss of $(0.01) in Q2 2025.
Gross margin increased to 44.5% in Q2 2026, up from 38.7% in Q2 2025.

CARMEL, Ind., Aug. 11, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), an integrated

Syra Health Achieves 23% Revenue Growth, Improves Gross Margin to 44.5% in Second Consecutive Profitable Quarter

Tue, 11 Aug 2026 07:55:00 -0400

Syra Health sustained profitability in Q2 2026, following the Company's first profitable quarter in Q1 2026, delivering net income of $250,242 compared with a net loss of $(63,596) in the prior-year period.
Q2 2026 revenue grew 23% year-over-year to $2.4 million.
Earnings per share (EPS) improved to $0.02 in Q2 2026 from a loss of $(0.01) in Q2 2025.
Gross margin increased to 44.5% in Q2 2026, up from 38.7% in Q2 2025.

CARMEL, Ind., Aug. 11, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), an integrated

Syra Health To Announce Second Quarter 2026 Financial Results

Tue, 04 Aug 2026 07:55:00 -0400

CARMEL, Ind., Aug. 4, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA), ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today that it will report financial results for the three months ended June 30, 2026, on Tuesday, August 11, 2026.

Syra Health To Announce Second Quarter 2026 Financial Results

Tue, 04 Aug 2026 07:55:00 -0400

Syra Health To Announce Second Quarter 2026 Financial Results

Tue, 04 Aug 2026 07:55:00 -0400

Syra Health To Announce Second Quarter 2026 Financial Results

Tue, 04 Aug 2026 07:55:00 -0400

Form 8-K Syra Health Corp For: Jul 23

Thu, 23 Jul 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260723/26808296.html

Form 8-K Syra Health Corp For: Jul 23

Thu, 23 Jul 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260723/26808296.html

Syra Health names Dr. Cori McMahon as fractional chief medical officer

Tue, 07 Jul 2026 08:55:12 -0400

Syra Health Corp. (OTCQB: SYRA) has appointed Dr. Cori McMahon, PsyD, NCCE, as Chief Medical Officer in a fractional capacity, the company announced July 7, 2026.

Dr. McMahon is a licensed behavioral medicine psychologist who also serves as a licensed psychologist at Cooper University Health Care. In her new role, she will provide clinical guidance to support the expansion of Syra Health's behavioral health and population health solutions, while strengthening engagement with healthcare stakeholders across commercial and public healthcare sectors.

"Dr. McMahon brings deep clinical expertise and significant experience aligned with Syra Health's solutions," said Greg Alexander, CEO of Syra Health. "Her

Syra Health names Dr. Cori McMahon as fractional chief medical officer

Tue, 07 Jul 2026 08:55:12 -0400

Syra Health Corp. (OTCQB: SYRA) has appointed Dr. Cori McMahon, PsyD, NCCE, as Chief Medical Officer in a fractional capacity, the company announced July 7, 2026.

"Dr. McMahon brings deep clinical expertise and significant experience aligned with Syra Health's solutions," said Greg Alexander, CEO of Syra Health. "Her

Syra Health names Dr. Cori McMahon as fractional chief medical officer

Tue, 07 Jul 2026 08:55:12 -0400

Syra Health Corp. (OTCQB: SYRA) has appointed Dr. Cori McMahon, PsyD, NCCE, as Chief Medical Officer in a fractional capacity, the company announced July 7, 2026.

"Dr. McMahon brings deep clinical expertise and significant experience aligned with Syra Health's solutions," said Greg Alexander, CEO of Syra Health. "Her

Syra Health names Dr. Cori McMahon as fractional chief medical officer

Tue, 07 Jul 2026 08:55:12 -0400

Syra Health Corp. (OTCQB: SYRA) has appointed Dr. Cori McMahon, PsyD, NCCE, as Chief Medical Officer in a fractional capacity, the company announced July 7, 2026.

"Dr. McMahon brings deep clinical expertise and significant experience aligned with Syra Health's solutions," said Greg Alexander, CEO of Syra Health. "Her

Syra Health Appoints Dr. Cori McMahon as Chief Medical Officer to Support its Growth Strategy

Tue, 07 Jul 2026 08:55:00 -0400

CARMEL, Ind., July 7, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today the appointment of Dr. Cori McMahon, PsyD, NCCE, as Chief Medical Officer.